$EUDA News

EUDA Health Launches Regenixé iPSC-derived Skin Stem Cell Secretome Mask; Regains Nasdaq Listing Compliance

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

EUDA Health Holdings Receives Nasdaq Listing Notice

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Reported Earlier: EUDA Health Announces 1-For-20 Reverse Stock Split Effective March 23, 2026

EUDA Announces Reverse Stock Split of its Ordinary Shares

EUDA Health price target lowered to $2.75 from $6 at Greenridge

Euda Health shares are trading lower after Greenridge Global lowered its price target on the stock from $6 to $2.75.

12 Health Care Stocks Moving In Monday's Intraday Session

Greenridge Global Maintains Buy on EUDA Health Holdings, Lowers Price Target to $2.75

EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant

EUDA Health Acquires, Cancels Previously Announced Warrants Of Streeterville Capital For $125K

EUDA Health Enters Second Amendment To Warrant Agreement With Streeterville To Further Reduce Exercise Price From $4/Share To $2/Share

EUDA Health Subsidiary Signs Loan Convertible Agreement With Shenzhen Inno Immune To Invest Up To RMB6M In Two Tranches

EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

EUDA Health Launched Its Nationwide Stem Cell Extraction, Cryogenic Storage, And Clinical Delivery Platform In China